Publications by authors named "Hagenacker Tim"

Claim this Profile
T
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis.
Christina Steffke, Karthik Baskar, Franziska Bachhuber, Maximilian Wiesenfarth, Johannes Dorst, Tim Hagenacker

Ann Neurol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment evolution in spinal muscular atrophy: insights from the SMArtCARE registry.
Cornelia Voigt-Müller, Michelle Pfaffenlehner, Günther Bernert, Hakan Cetin, Tim Hagenacker

Brain· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CT-guided Lumbar Puncture for Intrathecal Nusinersen Injection in Patients with Spinal Muscular Atrophy: Technical Effectiveness, Safety, and Radiation Dose.
Yannick Laurent Thal, Marcel Opitz, Raya Ocker-Serger, Laura Valentina Klüner, Daniel Rosok, Tim Hagenacker

Clin Neuroradiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Astrocytic Connexin 43 Mitigates Glutamate-Driven Motor Neuron Stress in Late-Onset Spinal Muscular Atrophy.
Schahin Salmanian, Linda-Isabell Schmitt, Kai Christine Liebig, Stefanie Hezel, Andreas Roos, Tim Hagenacker

Cells· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Növer et al. Prediction of Recurrence and Rupture Risk of Ruptured and Unruptured Intracranial Aneurysms of the Posterior Circulation: A Machine Learning-Based Analysis. 2025, , 2365.
Martin Növer, Hanna Styczen, Ramazan Jabbarli, Philipp Dammann, Martin Köhrmann, Tim Hagenacker

Diagnostics (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review and Meta-analysis of Long-Term Nusinersen Effectiveness in Adolescents and Adults with Spinal Muscular Atrophy.
Tim Hagenacker, Angela D Paradis, Katherine A Lawson-Michod, Bora Youn

Adv Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of autoimmune comorbidities on multiple sclerosis progression: insights from a longitudinal single-center study.
Derya Aslan, Sabrina Bourabia, Bernd Kowall, Agne Straukiene, Konstantin Fritz Jendretzky, Tim Hagenacker

J Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen - a multicenter observational study.
Claudia D Wurster, Benjamin Stolte, Tobias Kessler, Maren Freigang, Bogdan Bjelica, Tim Hagenacker

Orphanet J Rare Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic intrafamilial variability of 5q-associated spinal muscular atrophy: A systematic multicentre sibling study.
Benedikt Becker, Isabell Cordts, Jutta Becker, Rene Günther, Matthias Baumann, Tim Hagenacker

J Neuromuscul Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State of the art: Pregnancy in spinal muscular atrophy in the treatment era.
Maggie C Walter, Bernert Günther, Blaschek Astrid, Deschauer Marcus, Günther René, Hagenacker Tim

J Neuromuscul Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Recurrence and Rupture Risk of Ruptured and Unruptured Intracranial Aneurysms of the Posterior Circulation: A Machine Learning-Based Analysis.
Martin Növer, Hanna Styczen, Ramazan Jabbarli, Philipp Dammann, Martin Köhrmann, Tim Hagenacker

Diagnostics (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuronal Pentraxin 2 as a Potential Biomarker for Nusinersen Therapy Response in Adults with Spinal Muscular Atrophy: A Pilot Study.
Svenja Neuhoff, Linda-Isabell Schmitt, Kai Christine Liebig, Stefanie Hezel, Nick Isana Tilahun, Tim Hagenacker

Biomedicines· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral function tests in spinal muscular atrophy: closing the diagnostic gap in severely affected adult patients : A prospective observational study.
Teresa Kruse, Sara Portegys, Diana Leflerovà, Annette Cap, Brunhilde Wirth, Tim Hagenacker

J Orofac Orthop· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-occurrence of myositis and neuropathy after anti-CD30 therapy in a late-adolescent Hodgkin lymphoma patient.
Adela Della Marina, Lydia Rink, Andreas Hentschel, Michael M Schündeln, Christopher Nelke, Tim Hagenacker

Acta Neuropathol Commun· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the symptom control provided by ravulizumab or efgartigimod in myasthenia gravis: an evaluation of the patient experience of two different treatment approaches.
Christopher A Scheiner, Masayuki Masuda, Tim Hagenacker, Lauren Powell, Pramoda Jayasinghe

Curr Med Res Opin· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS).
Wolfgang Boehmerle, Tim Hagenacker, Markus Leo, Linda-Isabell Schmitt, Helmar C Lehmann

BMC Res Notes· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C5 complement inhibition versus FcRn modulation in generalised myasthenia gravis.
Niklas Huntemann, Lea Gerischer, Meret Herdick, Christopher Nelke, Frauke Stascheit, Tim Hagenacker

J Neurol Neurosurg Psychiatry· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Dynamics of CSF and Serum Neurofilament Light Chain in Adult Patients With 5q Spinal Muscular Atrophy Treated With Nusinersen.
Isabell Cordts, Cornelia Fuetterer, Annika Wachinger, Ricarda von Heynitz, Tobias Kessler, Tim Hagenacker

Neurology· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survival.
Sara Oubari, Maria Papathanasiou, Lars Michel, Tienush Rassaf, Andreas Thimm, Tim Hagenacker

Ann Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triiodothyronine treatment in mice improves stroke outcome and reduces blood-brain barrier damage.
Daniel Ullrich, Dagmar Führer, Heike Heuer, Steffen Mayerl, Steffen Haupeltshofer, Tim Hagenacker

Eur Thyroid J· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance fatigability in adults with spinal muscular atrophy treated long-term with nusinersen.
Benjamin Stolte, Svenja Neuhoff, Jaqueline Lipka, Melina Schlag, Otgonzul von Velsen, Tim Hagenacker

Muscle Nerve· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Nusinersen in Adolescents and Adults with Spinal Muscular Atrophy: Systematic Review and Meta-analysis.
Tim Hagenacker, Lorenzo Maggi, Giorgia Coratti, Bora Youn, Stephanie Raynaud

Neurol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy.
Vera Dobelmann, Andreas Roos, Andreas Hentschel, Adela Della Marina, Markus Leo, Tim Hagenacker

J Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral functions in adult persons with spinal muscular atrophy compared to a healthy control group: a prospective cross-sectional study with a multimodal approach.
Teresa Kruse, Diana Leflerovà, Annette Cap, Sara Portegys, Brunhilde Wirth, Tim Hagenacker

Orphanet J Rare Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iatrogenic botulism after intragastric botulinum neurotoxin injections - a major outbreak.
Tsepo Goerttler, Martin B Dorner, Christina van der Linden, Ricardo Kienitz, Stephan Petrik, Tim Hagenacker

Neurol Res Pract· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis